Britannia Announces Partial Repayment and Extension of Sellers’ Note Agreement
Toronto, Ontario–(Newsfile Corp. – January 5, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia”) is pleased to announce that it has entered into an agreement with the vendors of Advanced Development and...
Read more